 2006 Conference
Health Care
 programs at Wharton
2004 Conference
|
Panelists: Biotechnology Panel
Suzanne M. Sensabaugh
Vice President, Regulatory Affairs, Global Biogenerics
Teva Pharmaceutical Industries Ltd.
Suzanne M. Sensabaugh is VP, Regulatory Affairs, Global Biogenerics, Teva Pharmaceutical Industries Ltd., where she is responsible for the development of regulatory strategy and submissions for biotechnology products. Prior to this position, she was VP, RA & Quality, SICOR Inc., Biotechnology Division, where she was responsible for global regulatory affairs, quality assurance and control for biotechnology products. She has more than 10 years of experience at the FDA/CBER as a researcher, product reviewer, and inspector for biologics/biotechnology products. She also was extensively involved in the development and implementation of SOPs, Guidance, regulations, and laws. Prior to leaving the Agency, she was Special Assistant to the Associate Director of Policy, Office of the Center Director. She then moved to industry as Associate Director, Regulatory Affairs, at Genzyme Corporation. In this position, Ms. Sensabaugh directed, planned, and implemented global regulatory activities for biotechnology products. Ms. Sensabaugh received her MBA from Duke University, MS in Biotechnology from Johns Hopkins University, and BS in Zoology from the University of Maryland, College Park.
|
